Literature DB >> 6777436

Role of magnesium in the enzyme-linked immunosorbent assay for lipopolysaccharides of rough Escherichia coli strain J5 and Neisseria gonorrhoeae.

J I Ito, A C Wunderlich, J Lyons, C E Davis, D G Guiney, A I Braude.   

Abstract

An enzyme-linked immunosorbent assay for antibody to the lipopolysaccharides (LPSs) of a rough strain of Escherichia coli (J5) and Neisseria gonorrhoeae was developed. When standard methods of this assay were applied to these LPSs, no antibody was measured. By radiolabeling smooth and rough endotoxins with 51Cr, it was discovered that the rough LPS was not adhering to the polystyrene tubes. When Mg++ was added, however, all endotoxins absorbed to the solid phase. With this assay antiserum to core glycolipid had higher titers against its smooth parent strain than did homologous glycolipid had higher titers against its smooth parent strain that did homologous antiserum, and antisera to gonococci had high homologous but low heterologous titers. Thus, these data demonstrate that bulky O side chains do not hinder the penetration of antibody to core glycolipid and that LPSs from gonococci are heterogeneous but do cross-react.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777436     DOI: 10.1093/infdis/142.4.532

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens.

Authors:  M A Freudenberg; A Fomsgaard; I Mitov; C Galanos
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

2.  Production and epitope analysis of monoclonal antibodies against a Rhizobium leguminosarum biovar trifolii strain.

Authors:  S F Wright
Journal:  Appl Environ Microbiol       Date:  1990-07       Impact factor: 4.792

3.  Optimization and standardization of an enzyme-linked immunosorbent assay protocol for serodiagnosis of Actinobacillus pleuropneumoniae serotype 5.

Authors:  Y L Trottier; P F Wright; S Larivière
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

Review 4.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

5.  Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine.

Authors:  B W Fenwick; J S Cullor; B I Osburn; H J Olander
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

6.  Variations in the carbohydrate regions of Bordetella pertussis lipopolysaccharides: electrophoretic, serological, and structural features.

Authors:  M Caroff; R Chaby; D Karibian; J Perry; C Deprun; L Szabó
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

7.  Quantitation of rabbit immunoglobulin G antibodies to Salmonella minnesota Re by enzyme-linked immunosorbent assay.

Authors:  M Eskenazy; F Naumova; R Tekelieva; G Konstantinov
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

8.  Production and characterization of monoclonal antibodies to type 8 lipooligosaccharide of Neisseria meningitidis.

Authors:  X X Gu; C M Tsai; A B Karpas
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

9.  Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.

Authors:  H J Jennings; C Lugowski; F E Ashton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

10.  Monoclonal antibody against bacterial lipopolysaccharide cross-reacts with DNA-histone.

Authors:  R Sumazaki; T Fujita; T Kabashima; F Nishikaku; A Koyama; M Shibasaki; H Takita
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.